Related Experiment Video
Updated: Jul 9, 2026
Experimental Metastasis Assay
Published on: August 24, 2010
Iris metastasis in small-cell lung carcinoma
Anke W J Roenhorst1, Alphons C M van den Bergh, John W G van Putten
1Department of Pulmonology, University Medical Center Groningen, Groningen, the Netherlands. ankeroenhorst@cs.com
Abstract:
Small-cell lung cancer (SCLC) is characterized by rapid growth and early metastasis. Despite its sensitivity to cytotoxic treatment, until now treatments have failed to control or cure this disease in most patients. Here, we describe a patient with SCLC in which symptoms caused by iris metastasis were the only sign of relapse after multimodality treatment.
Insights
Small-cell lung cancer (SCLC) often relapses aggressively. In one patient, iris metastasis was the sole indicator of SCLC relapse after treatment.
Area of Science:
- Oncology
- Ophthalmology
Background:
- Small-cell lung cancer (SCLC) exhibits aggressive proliferation and early metastatic spread.
- Current cytotoxic treatments offer limited long-term control or cure for most SCLC patients.
Observation:
- A patient with SCLC presented with symptoms solely due to iris metastasis.
- This ocular metastasis was the only clinical sign of disease recurrence following comprehensive multimodality treatment.
Findings:
- Iris metastasis can be the exclusive manifestation of SCLC relapse.
- This case highlights the importance of considering ocular involvement in SCLC recurrence.
Implications:
- Ophthalmologic examination may be crucial for detecting SCLC relapse.
- This finding could influence diagnostic strategies for recurrent SCLC.
